Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

Why is there still no dengue vaccine in the country?” This was the question posed by Union of Local Authorities of the Philippines president and Quirino governor Dax Cua to the Department of Health, a ...

Ecuador's Health Ministry confirmed Thursday that the South American country was going through a dengue epidemic.

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top ...

India experiences the world’s absolute burden of at least 11 NTDs, including hookworm, dengue, lymphatic filariasis, leprosy, ...

Queensland Health staff in Townsville are treating an elderly man with dengue fever and a middle ... commonly water birds or pigs. JEV is a vaccine-preventable disease. Infection in humans ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Over the next few years, Takeda plans to expand its focus on therapeutic areas such as inflammation, oncology, and rare conditions, with investments in plasma-derived therapies and vaccines, Ricci ...